Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2022

Conditions
Severe Hypoxic-ischemic Encephalopathy
Interventions
DRUG

HPDSC

Autologous HPDSC collected after birth will be infused in aliquots. one-half of the HPDSC infused on Day 2; one-half of the collected HPDSC will be infused on Day 8.

DRUG

Cord blood

Autologous Cord Blood collected after birth will be infused in aliquots. One-third of the collected cord blood will be infused within the first 24 hours after birth (Day 0); one-third of the collected cord blood will be infused on day 3; and one-third of the collected cord blood unit will be infused on Day 7.

Trial Locations (1)

10595

New York Medical College, Valhalla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

New York Medical College

OTHER